hmnr asg
Senior Member
- Messages
- 571
What about 3PPP ?I think we need a low dose selective presynaptic dopamine agonist (ideally with a short half-life), to achieve a steady state of increased synaptic dopamine, the same principle as in low dose naltrexone really. Antagonism of presynaptic receptor will eventually lead to up-regulation and decreased dopamine output.
https://en.wikipedia.org/wiki/3-PPP